NASDAQ:ASPX (ASPX) (ASPX) Stock Price, News & Analysis → 4x Better than Bitcoin (From Behind the Markets) (Ad) Free ASPX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.02 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ASPX) alerts: Email Address Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About (ASPX) Stock (NASDAQ:ASPX)Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.Read More Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> ASPX Stock News HeadlinesMarch 29, 2024 | yahoo.comYour guide to things to do in Asheville and across Western North Carolina! April 2024March 29, 2024 | msn.comPic Shows Saudi Prince's 80 Falcons Riding a Plane?March 29, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 29, 2024 | msn.comSRM Contractors IPO allotment status: Check application, latest GMP and listing dateMarch 29, 2024 | msn.comAn ActRIIA fusion protein got FDA approved for PAH treatmentMarch 28, 2024 | msn.comABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cellsMarch 28, 2024 | msn.comACLU Argues Minors Are ‘Harmed’ By Michigan Law Requiring Parental Consent For AbortionsMarch 28, 2024 | msn.comPennsylvania State Police unveil new tip line to help with active investigationsMarch 29, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 28, 2024 | msn.comPennsylvania State Police unveils 'PSP Tips' for public to share informationMarch 28, 2024 | msn.comUjjivan Small Finance Bank Ties-up with Veefin Solutions Ltd to Offer Better Supply Chain Finance Offerings to MSMEsMarch 28, 2024 | msn.comBayern waits on Kane's and Neuer's fitness for 'Klassiker' against DortmundMarch 27, 2024 | msn.comHere are Thurston County food safety scores for March 27March 27, 2024 | finance.yahoo.comMedinCell to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 27, 2024 | msn.com2 separate shootings overnight end with 3 shot in bed, including childMarch 27, 2024 | msn.comSearch for missing Texas A&M student deepens in Oso Bay Wetlands PreserveMarch 27, 2024 | msn.comHere's who's running for county attorney, sheriff and supervisor in Dallas County in 2024March 27, 2024 | msn.comHere's who is running for Polk County supervisor in two competitive races in 2024March 26, 2024 | msn.comJihadist risks shake Tajik society after Moscow attackMarch 26, 2024 | msn.comVitamin D receptor presence in breast cancer tumors linked to better survival outcomesMarch 26, 2024 | msn.comFeedback loop involving estrogen linked to women's higher propensity to nicotine addictionMarch 25, 2024 | msn.comInteractive: Data From 9,500 Districts Shows Another Boom Year for School Staffing Even as Fiscal Cliff LoomsMarch 25, 2024 | msn.comStudy investigates the relationship between dietary inflammatory index and stroke risk in US adultsMarch 25, 2024 | msn.comDeadlines for utility assistance approaching this week in KansasMarch 25, 2024 | msn.comParental dilemmas: Deciding when to keep a child home from schoolMarch 25, 2024 | msn.comYoung child hurt when apartments are hit with gunfireMarch 25, 2024 | msn.comNew compound shows promise as a more effective treatment for schistosomiasisSee More Headlines Receive ASPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2015Today3/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ASPX CUSIPN/A CIK1454189 WebN/A Phone+1-858-5582400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report ASPX Stock Analysis - Frequently Asked Questions How were (ASPX)'s earnings last quarter? (ASPX) (NASDAQ:ASPX) posted its quarterly earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) earnings per share for the quarter, missing analysts' consensus estimates of ($0.59) by $0.15. What other stocks do shareholders of (ASPX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), GoPro (GPRO), Ambarella (AMBA), Alkermes (ALKS), Align Technology (ALGN), Akebia Therapeutics (AKBA), Agios Pharmaceuticals (AGIO), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS). This page (NASDAQ:ASPX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ASPX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.